April 10, 2020

April 09, 2020

Subscribe to Latest Legal News and Analysis

April 08, 2020

Subscribe to Latest Legal News and Analysis

April 07, 2020

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
3
Jun
Health Care Law Update - June 2, 2014 Mintz
3
Jun
New Minnesota Medical Cannabis Law Protects Employees From Discrimination For Medical Marijuana Use Jackson Lewis P.C.
2
Jun
Federal Court Vacates 340B Rule Regarding Orphan Drugs McDermott Will & Emery
2
Jun
FDA Ups the Ante on Inspections with New Administrative Detention Authority Morgan, Lewis & Bockius LLP
31
May
Developer-Prepared Cost Comparisons Can Show Economic Infeasibility Under CEQA - California Environmental Quality Act Sheppard, Mullin, Richter & Hampton LLP
30
May
What Is “a Patient?” McDermott Will & Emery
30
May
Settlement Between U.S. Department of Labor and Oregon Blueberry Growers Vacated Varnum LLP
29
May
Combining Two Drugs Is Not Always Obvious: Sanofi-Aventis Deutschland GMBH v. Glenmark Pharmaceuticals Inc. McDermott Will & Emery
29
May
Design Patents Go to the Dogs: District Court Not Required to Provide an Express Verbal Description of the Claimed Design McDermott Will & Emery
29
May
A Combination of References Need Only Provide a “Reasonable Expectation of Success” McDermott Will & Emery
29
May
An Overview of Biosimilars in the Russian Federation Michael Best & Friedrich LLP
28
May
340B Orphan Drug Rule Invalid Faegre Drinker
28
May
Energy & Environmental Law Update - May 27, 2014 Mintz
28
May
Court Invalidates 340B Orphan Drug Rule Mintz
28
May
Food and Drug Administration (FDA) Issues Draft Guidance on Appropriate Use of Voluntary Consensus Standards in Medical Device Submissions Barnes & Thornburg LLP
27
May
Michigan Commission of Agriculture Approves Revised Generally Accepted Agricultural and Management Practices' (GAAMP) Limiting Scope of Right to Farm Act Varnum LLP
23
May
2013-2014 Wisconsin Legislative Session Ends & Three Additional Agriculture Bills Signed Into Law Michael Best & Friedrich LLP
23
May
Geographical Indicators - A Cheese by Any Other Name, Would it Taste as Good? Michael Best & Friedrich LLP
23
May
Five Things Every Arizona Employer Should Know About Medical Marijuana Ryley Carlock & Applewhite, A Professional Corporation
23
May
Senate Republicans Press Food and Drug Association on Draft Guidances Covington & Burling LLP

Pages

TRENDING LEGAL ANALYSIS